Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice.

[1]  J. Aberg,et al.  Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220. , 2010, Vaccine.

[2]  H. Bush,et al.  Role of CD4 Count in Immunity Development After Hepatitis A and B Vaccination Among HIV-Infected Patients: Kentucky, 2002-2007 , 2010, Journal of the International Association of Physicians in AIDS Care.

[3]  L. Camacho,et al.  High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects. , 2010, Vaccine.

[4]  B. Aqel,et al.  Antibody response to hepatitis B vaccine in substance use disorder patients. , 2010, Drug and alcohol dependence.

[5]  V. Sharp,et al.  Efficacy of double-dose hepatitis B rescue vaccination in HIV-infected patients. , 2010, AIDS patient care and STDs.

[6]  P. Malani,et al.  Factors Associated With Seroconversion After Standard Dose Hepatitis B Vaccination and High-Dose Revaccination Among HIV-Infected Patients , 2010, HIV clinical trials.

[7]  K. H. Hullsiek,et al.  Hepatitis B vaccine responses in a large U.S. military cohort of HIV-infected individuals: another benefit of HAART in those with preserved CD4 count. , 2009, Vaccine.

[8]  R. Vandenberg,et al.  Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions. , 2009 .

[9]  C. Mengoli,et al.  Serologic response to hepatitis B vaccine with high dose and increasing number of injections in HIV infected adult patients. , 2009, Vaccine.

[10]  C. Bailey,et al.  Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults. , 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[11]  L. Paitoonpong,et al.  Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy , 2008, Scandinavian journal of infectious diseases.

[12]  A. Duarte,et al.  Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naïve) and CD45RO+ (memory) subsets in HIV-1-infected subjects. , 2006, Vaccine.

[13]  Y. Chawla,et al.  Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccine , 2006, BMC infectious diseases.

[14]  W. Powderly,et al.  Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  A. Barone,et al.  Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. , 2005, Vaccine.

[16]  A. Moorman,et al.  Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  L. Lasagna.  A plea for the “naturalistic” study of medicines , 2004, European Journal of Clinical Pharmacology.

[18]  K. Leder,et al.  The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  M. Dietrich,et al.  A new accelerated vaccination schedule for rapid protection against hepatitis A and B. , 2002, Vaccine.

[20]  J. Lang,et al.  Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. , 2000, Vaccine.

[21]  W. Jilg.  Novel hepatitis B vaccines. , 1998, Vaccine.

[22]  H. Margolis,et al.  Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection. , 1998, American journal of preventive medicine.

[23]  B. Donovan,et al.  Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4+ lymphocyte count and vaccination schedule. , 1996, International journal of STD & AIDS.

[24]  F. Miedema,et al.  Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4+ cell counts. , 1994, The Journal of infectious diseases.

[25]  V. Martín,et al.  Hepatitis B vaccination in prisons: the Catalonian experience. , 1993, Vaccine.

[26]  M. Bruguera,et al.  Impaired Response to Recombinant Hepatitis B Vaccine in HIV‐Infected Persons , 1992, Journal of clinical gastroenterology.

[27]  A. Zuckerman,et al.  Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: An indicator of poor prognosis , 1990, Journal of medical virology.

[28]  S. Hadler,et al.  Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. , 1989, Vaccine.

[29]  H. Handsfield,et al.  Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. , 1988, Annals of internal medicine.

[30]  W. Szmuness,et al.  Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. , 1982, The New England journal of medicine.